The exciting program, with leading state-of-the art speakers and students from all over Europe, put an emphasis on SARS-CoV-2. Discussions included neutralizing antibody responses to SARS-CoV-2 variants, vaccines, other viral agents, antiviral vaccine vectors, and vaccine development against SARS-CoV-2.
In addition to SARS-CoV-2, other viral infections were also well-represented, including intrinsic restriction factors to HIV and herpesviruses (including CMV), innate immune resistance hubs, NK cells, trained innate immunity, and mucosal immunity.
The meeting was a great success with outstanding invited talks, excellent student presentations (including open presentation of unpublished data), and exceptional audience participation with in-depth discussions about each talk.
Due to current regulations we limited the onsite registration to 70 participants, which turned out to be a perfect size for close scientific interactions.
